Improvement of Endothelial Function With Dietary Flavanols Is Associated With Mobilization of Circulating Angiogenic Cells in Patients With Coronary Artery Disease

Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced n...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 56; no. 3; pp. 218 - 224
Main Authors: Heiss, Christian, MD, DrMed, Jahn, Sarah, MB, Taylor, Melanie, BS, Real, Wendy May, BS, Angeli, Franca S., MD, Wong, Maelene L., BS, Amabile, Nicolas, MD, Prasad, Megha, BA, Rassaf, Tienush, MD, DrMed, Ottaviani, Javier I., PhD, Mihardja, Shirley, PhD, Keen, Carl L., PhD, Springer, Matthew L., PhD, Boyle, Andrew, MBBS, PhD, Grossman, William, MD, Glantz, Stanton A., PhD, Schroeter, Hagen, PhD, Yeghiazarians, Yerem, MD
Format: Journal Article
Language:English
Published: New York, NY Elsevier Inc 13-07-2010
Elsevier
Elsevier Limited
Subjects:
NO
SDF
LDL
FMD
CAC
CAD
SCF
BA
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Background Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. Methods In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Results Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+ /KDR+ -CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: −4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+ /KDR+ -CACs. Conclusions Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774 ).
AbstractList Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Background Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. Methods In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Results Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+ /KDR+ -CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: −4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+ /KDR+ -CACs. Conclusions Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774 ).
OBJECTIVESIn patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs).BACKGROUNDDietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function.METHODSIn a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64+/-3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days.RESULTSEndothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: -4.2+/-2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74+/-32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs.CONCLUSIONSSustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774).
In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64+/-3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: -4.2+/-2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74+/-32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs. Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774).
In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: −4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs. Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774).
Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs). Background Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function. Methods In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64 ± 3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days. Results Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: -4.2 ± 2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74 ± 32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs. Conclusions Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation;NCT00553774).
Author Glantz, Stanton A., PhD
Springer, Matthew L., PhD
Real, Wendy May, BS
Yeghiazarians, Yerem, MD
Mihardja, Shirley, PhD
Heiss, Christian, MD, DrMed
Wong, Maelene L., BS
Ottaviani, Javier I., PhD
Angeli, Franca S., MD
Keen, Carl L., PhD
Schroeter, Hagen, PhD
Boyle, Andrew, MBBS, PhD
Prasad, Megha, BA
Jahn, Sarah, MB
Grossman, William, MD
Taylor, Melanie, BS
Amabile, Nicolas, MD
Rassaf, Tienush, MD, DrMed
Author_xml – sequence: 1
  fullname: Heiss, Christian, MD, DrMed
– sequence: 2
  fullname: Jahn, Sarah, MB
– sequence: 3
  fullname: Taylor, Melanie, BS
– sequence: 4
  fullname: Real, Wendy May, BS
– sequence: 5
  fullname: Angeli, Franca S., MD
– sequence: 6
  fullname: Wong, Maelene L., BS
– sequence: 7
  fullname: Amabile, Nicolas, MD
– sequence: 8
  fullname: Prasad, Megha, BA
– sequence: 9
  fullname: Rassaf, Tienush, MD, DrMed
– sequence: 10
  fullname: Ottaviani, Javier I., PhD
– sequence: 11
  fullname: Mihardja, Shirley, PhD
– sequence: 12
  fullname: Keen, Carl L., PhD
– sequence: 13
  fullname: Springer, Matthew L., PhD
– sequence: 14
  fullname: Boyle, Andrew, MBBS, PhD
– sequence: 15
  fullname: Grossman, William, MD
– sequence: 16
  fullname: Glantz, Stanton A., PhD
– sequence: 17
  fullname: Schroeter, Hagen, PhD
– sequence: 18
  fullname: Yeghiazarians, Yerem, MD
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23038813$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20620742$$D View this record in MEDLINE/PubMed
BookMark eNp9klFrFDEQxxep2Gv1C_ggCyI-3TnZ7G4SkMKx7elBRUHFx5DNzl5z5pKa7B7Ur-MXNeudFvogBIYkv_9kMv85y06cd5hlzwksCJD6zXaxVVovCkgHQNMSj7IZqSo-p5VgJ9kMGK3mBAQ7zc5i3AJAzYl4kp0WUBfAymKW_VrvboPf4w7dkPs-v3KdH27QGmXz1ej0YLzLv5nhJr80OKhwl6-s2ivnbczXMV_G6LVRA3YH6INvjTU_1R9ZSteYoEebtm6TL93G-A06o_MGbdIbl39KV-nleFA3Png3vbEMA6ZwaSKqiE-zx72yEZ8d43n2dXX1pXk_v_74bt0sr-e6IsUwV0UtAAqCFeNckbZtQdStYAiq7bpekF71lHHRdjXhhEPPVYm8LDgjvATW0fPs9SFv6siPEeMgdybqVKpy6McoGaWCl1UhEvnyAbn1Y3CpOEmq1FsGrC4TVRwoHXyMAXt5G8wu_U8SkJODcisnB-XkoASa1pT6xTH12O6w-yf5a1kCXh0BFbWyfVBOm3jPUaCcE5q4twcOU8v2BoOMOvVaY2cC6kF23vy_josHcm1N8k7Z73iH8f6_MhYS5Odp1qZRIwCE0bqivwHNEdFf
CODEN JACCDI
CitedBy_id crossref_primary_10_1080_07315724_2018_1451788
crossref_primary_10_1016_j_freeradbiomed_2011_12_010
crossref_primary_10_1111_jch_12715
crossref_primary_10_1089_ars_2014_6158
crossref_primary_10_1089_jmf_2018_0209
crossref_primary_10_1017_S0007114516002348
crossref_primary_10_3945_jn_111_152470
crossref_primary_10_1016_j_jff_2016_03_024
crossref_primary_10_1161_HYPERTENSIONAHA_110_158139
crossref_primary_10_3390_jcdd11060174
crossref_primary_10_52711_0974_360X_2023_00052
crossref_primary_10_1017_S0007114515002822
crossref_primary_10_1152_ajpcell_00406_2010
crossref_primary_10_3390_nu16010041
crossref_primary_10_1016_j_freeradbiomed_2014_12_009
crossref_primary_10_1177_0003319718774660
crossref_primary_10_1007_s11357_015_9794_9
crossref_primary_10_1177_1934578X1501001118
crossref_primary_10_1093_eurheartj_ehq332
crossref_primary_10_3390_nu13041103
crossref_primary_10_3945_ajcn_111_023457
crossref_primary_10_1002_ptr_5665
crossref_primary_10_3945_ajcn_111_028340
crossref_primary_10_1016_j_abb_2012_02_021
crossref_primary_10_1039_C4FO00570H
crossref_primary_10_3389_fcvm_2021_632131
crossref_primary_10_3390_antiox8120650
crossref_primary_10_1161_CIRCULATIONAHA_112_112912
crossref_primary_10_1161_JAHA_114_001472
crossref_primary_10_1111_j_1467_3010_2012_01984_x
crossref_primary_10_1051_bioconf_20236804004
crossref_primary_10_3390_biomedicines11113051
crossref_primary_10_1007_s11906_012_0281_8
crossref_primary_10_2174_1570159X21666221031103909
crossref_primary_10_3390_nu12041098
crossref_primary_10_3390_nu10080986
crossref_primary_10_1016_j_atherosclerosis_2018_04_012
crossref_primary_10_1016_j_tetlet_2012_01_054
crossref_primary_10_1089_ars_2012_4581
crossref_primary_10_1093_ajcn_nqy066
crossref_primary_10_1016_j_dib_2018_04_149
crossref_primary_10_1080_21551197_2012_702541
crossref_primary_10_1016_j_vph_2015_02_010
crossref_primary_10_1016_j_redox_2013_12_015
crossref_primary_10_1021_acs_jafc_5b01064
crossref_primary_10_1093_ajcn_nqy229
crossref_primary_10_1038_s41598_020_74863_7
crossref_primary_10_1152_japplphysiol_01302_2012
crossref_primary_10_1038_srep29034
crossref_primary_10_1039_C8FO00483H
crossref_primary_10_1017_S0007114513003693
crossref_primary_10_3390_molecules24234295
crossref_primary_10_3390_antiox8040088
crossref_primary_10_3945_ajcn_113_066639
crossref_primary_10_1007_s12170_011_0157_5
crossref_primary_10_3945_ajcn_113_071274
crossref_primary_10_1017_S0007114516004219
crossref_primary_10_1177_1074248416639719
crossref_primary_10_1016_j_foodchem_2014_06_107
crossref_primary_10_1007_s13668_013_0058_y
crossref_primary_10_1007_s10298_013_0764_z
crossref_primary_10_3390_ijms23010183
crossref_primary_10_1017_S0007114512000475
crossref_primary_10_1016_j_freeradbiomed_2012_02_051
crossref_primary_10_1152_ajplung_00215_2010
crossref_primary_10_1016_j_mam_2010_09_008
crossref_primary_10_3945_jn_111_145482
crossref_primary_10_3389_fimmu_2017_00677
crossref_primary_10_3945_ajcn_110_000075
crossref_primary_10_3945_ajcn_111_029330
crossref_primary_10_3390_diseases4040039
crossref_primary_10_1016_j_mam_2017_12_001
crossref_primary_10_1016_j_ijcard_2011_06_091
crossref_primary_10_1089_ars_2010_3697
crossref_primary_10_15446_rfnam_v68n1_47836
crossref_primary_10_3390_nu13051646
crossref_primary_10_3945_ajcn_115_116178
crossref_primary_10_1002_mnfr_201200595
crossref_primary_10_1039_D3FO01116J
crossref_primary_10_3390_nu7075177
crossref_primary_10_1093_cvr_cvac095
crossref_primary_10_1161_HYPERTENSIONAHA_112_193060
crossref_primary_10_1016_j_mvr_2018_10_008
crossref_primary_10_1177_2047487318800072
crossref_primary_10_1373_clinchem_2011_167361
crossref_primary_10_1016_j_heliyon_2024_e24430
crossref_primary_10_1016_j_maturitas_2011_05_011
crossref_primary_10_1016_j_atherosclerosis_2012_06_007
crossref_primary_10_3390_nu8060321
crossref_primary_10_1017_S0954422417000105
crossref_primary_10_1016_j_advnut_2023_01_002
crossref_primary_10_1002_ehf2_12077
crossref_primary_10_1590_1981_6723_19416
crossref_primary_10_3390_nu7125519
crossref_primary_10_1080_1028415X_2023_2298098
crossref_primary_10_1007_s11883_011_0203_2
crossref_primary_10_1016_j_clnme_2013_02_003
crossref_primary_10_1017_S0954422413000036
crossref_primary_10_1007_s12263_011_0255_5
crossref_primary_10_1021_acs_jafc_2c04519
crossref_primary_10_1017_S0954422420000049
crossref_primary_10_1152_japplphysiol_00865_2011
crossref_primary_10_3389_fnut_2017_00036
crossref_primary_10_3945_ajcn_116_140046
crossref_primary_10_1016_j_clnu_2020_06_039
crossref_primary_10_1038_leu_2011_184
crossref_primary_10_1002_mnfr_201600045
crossref_primary_10_1016_j_healun_2015_03_004
crossref_primary_10_1093_jn_nxy005
crossref_primary_10_2215_CJN_05560515
crossref_primary_10_1016_j_nut_2010_10_013
crossref_primary_10_1017_S0007114514003353
crossref_primary_10_1039_D1FO02369A
crossref_primary_10_1016_j_abb_2014_03_014
crossref_primary_10_1080_10408398_2023_2248506
crossref_primary_10_2903_j_efsa_2012_2809
crossref_primary_10_5567_pharmacologia_2015_21_30
crossref_primary_10_1016_j_tetasy_2013_02_012
crossref_primary_10_3390_ijms22094665
crossref_primary_10_1017_S0007114511002996
crossref_primary_10_1002_14651858_CD008893_pub3
crossref_primary_10_1016_j_clnesp_2019_10_017
crossref_primary_10_1016_j_fct_2012_05_013
crossref_primary_10_1016_j_freeradbiomed_2011_09_010
crossref_primary_10_1016_j_abb_2018_03_004
crossref_primary_10_1016_j_phanu_2016_05_002
crossref_primary_10_1016_j_ijcard_2012_10_047
crossref_primary_10_1002_mnfr_202100991
crossref_primary_10_1007_s00394_012_0334_4
crossref_primary_10_1016_j_jff_2012_09_002
crossref_primary_10_1089_ars_2019_7922
crossref_primary_10_1016_j_niox_2012_05_003
crossref_primary_10_1039_D3FO01737K
crossref_primary_10_3109_07853890_2010_543920
crossref_primary_10_1139_apnm_2015_0543
crossref_primary_10_1021_np300568m
crossref_primary_10_1097_FJC_0b013e318269ae0d
crossref_primary_10_1146_annurev_nutr_071811_150642
crossref_primary_10_1039_C9FO01747J
crossref_primary_10_1016_j_mam_2017_10_003
Cites_doi 10.1073/pnas.0510168103
10.1038/nchembio.260
10.1016/j.jacc.2006.09.050
10.1161/CIRCULATIONAHA.108.827022
10.1093/ajcn/81.1.317S
10.1007/s00109-004-0580-x
10.1016/j.jacc.2004.12.074
10.1056/NEJMoa043814
10.1016/j.jacc.2006.04.026
10.1097/FJC.0b013e31802d0001
10.1016/j.jacc.2008.01.059
ContentType Journal Article
Copyright American College of Cardiology Foundation
2010 American College of Cardiology Foundation
2015 INIST-CNRS
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Jul 13, 2010
Copyright_xml – notice: American College of Cardiology Foundation
– notice: 2010 American College of Cardiology Foundation
– notice: 2015 INIST-CNRS
– notice: Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Jul 13, 2010
DBID 6I.
AAFTH
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.jacc.2010.03.039
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
EndPage 224
ExternalDocumentID 3243094561
10_1016_j_jacc_2010_03_039
20620742
23038813
S0735109710017365
1_s2_0_S0735109710017365
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: N30 Pharmaceuticals
– fundername: American Heart Association
– fundername: Mars, Inc.
– fundername: Mars Inc.
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
0SF
18M
1B1
1CY
1P~
1~.
1~5
29L
2WC
3O-
3V.
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
6PF
7-5
71M
7RV
8P~
AABNK
AABVL
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AAKUH
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAXUO
AAYOK
ABBQC
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABVKL
ABXDB
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ADBBV
ADEZE
ADMUD
ADVLN
AEFWE
AEKER
AENEX
AEVXI
AEXQZ
AFCTW
AFETI
AFFNX
AFRAH
AFRHN
AFTJW
AGHFR
AGYEJ
AHMBA
AITUG
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
BENPR
BLXMC
BPHCQ
CS3
DIK
DU5
E3Z
EBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FNPLU
G-Q
GBLVA
GX1
H13
HVGLF
HX~
HZ~
IHE
IXB
J1W
J5H
K-O
KQ8
L7B
MO0
N4W
N9A
NCXOZ
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
QTD
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSZ
T5K
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
X7M
XPP
YYM
YYP
YZZ
Z5R
ZGI
ZXP
AAIAV
EFLBG
LCYCR
NAHTW
ZA5
08R
AAUGY
AKALU
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c512t-a2690021e5788a1bbb096b97e0abddf91faf3789bd618180f8a4e8428718407d3
ISSN 0735-1097
IngestDate Fri Oct 25 04:01:44 EDT 2024
Thu Oct 10 22:44:47 EDT 2024
Thu Sep 12 17:31:03 EDT 2024
Tue Oct 15 23:38:20 EDT 2024
Sun Oct 22 16:02:09 EDT 2023
Fri Feb 23 02:26:31 EST 2024
Tue Oct 15 22:53:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords coronary artery disease
NO
LoFI
HiFI
flow-mediated vasodilation
angiogenic cells
SDF
high-flavanol intervention
LDL
FMD
nitric oxide
stem cell factor
CAC
VEGF
CAD
flavanols
stromal cell-derived factor
low-density lipoprotein
circulating angiogenic cell
brachial artery
nutrition
vascular endothelial growth factor
low-flavanol intervention
SCF
flow-mediated dilation
BA
Human
Mobilization
Improvement
Diet therapy
Diet
Cardiovascular disease
Patient
Circulatory system
Endothelial function
Cardiology
Coronary heart disease
Cell
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
CC BY 4.0
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c512t-a2690021e5788a1bbb096b97e0abddf91faf3789bd618180f8a4e8428718407d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://dx.doi.org/10.1016/j.jacc.2010.03.039
PMID 20620742
PQID 1506270764
PQPubID 2031078
PageCount 7
ParticipantIDs proquest_miscellaneous_733984529
proquest_journals_1506270764
crossref_primary_10_1016_j_jacc_2010_03_039
pubmed_primary_20620742
pascalfrancis_primary_23038813
elsevier_sciencedirect_doi_10_1016_j_jacc_2010_03_039
elsevier_clinicalkeyesjournals_1_s2_0_S0735109710017365
PublicationCentury 2000
PublicationDate 2010-07-13
PublicationDateYYYYMMDD 2010-07-13
PublicationDate_xml – month: 07
  year: 2010
  text: 2010-07-13
  day: 13
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: New York
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2010
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Shantsila, Watson, Lip (bib5) 2007; 49
Lundberg, Gladwin, Ahluwalia (bib10) 2009; 5
Smith, Allen, Blair (bib6) 2006; 47
Corti, Flammer, Hollenberg, Luscher (bib2) 2009; 119
Dimmeler, Zeiher (bib4) 2004; 82
Heiss, Keymel, Niesler, Ziemann, Kelm, Kalka (bib8) 2005; 45
Heiss, Finis, Kleinbongard (bib9) 2007; 49
Arts, Hollman (bib1) 2005
Balzer, Rassaf, Heiss (bib11) 2008; 51
Werner, Kosiol, Schiegl (bib3) 2005; 353
Schroeter, Heiss, Balzer (bib7) 2006; 103
Dimmeler (10.1016/j.jacc.2010.03.039_bib4) 2004; 82
Shantsila (10.1016/j.jacc.2010.03.039_bib5) 2007; 49
Heiss (10.1016/j.jacc.2010.03.039_bib8) 2005; 45
Arts (10.1016/j.jacc.2010.03.039_bib1) 2005
Werner (10.1016/j.jacc.2010.03.039_bib3) 2005; 353
Smith (10.1016/j.jacc.2010.03.039_bib6) 2006; 47
Schroeter (10.1016/j.jacc.2010.03.039_bib7) 2006; 103
Heiss (10.1016/j.jacc.2010.03.039_bib9) 2007; 49
Balzer (10.1016/j.jacc.2010.03.039_bib11) 2008; 51
Lundberg (10.1016/j.jacc.2010.03.039_bib10) 2009; 5
Corti (10.1016/j.jacc.2010.03.039_bib2) 2009; 119
References_xml – volume: 47
  start-page: 2130
  year: 2006
  end-page: 2139
  ident: bib6
  article-title: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Blair
– volume: 49
  start-page: 741
  year: 2007
  end-page: 752
  ident: bib5
  article-title: Endothelial progenitor cells in cardiovascular disorders
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Lip
– volume: 82
  start-page: 671
  year: 2004
  end-page: 677
  ident: bib4
  article-title: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?
  publication-title: J Mol Med
  contributor:
    fullname: Zeiher
– volume: 45
  start-page: 1441
  year: 2005
  end-page: 1448
  ident: bib8
  article-title: Impaired progenitor cell activity in age-related endothelial dysfunction
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Kalka
– volume: 103
  start-page: 1024
  year: 2006
  end-page: 1029
  ident: bib7
  article-title: (−)-epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Balzer
– volume: 49
  start-page: 74
  year: 2007
  end-page: 80
  ident: bib9
  article-title: Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week
  publication-title: J Cardiovasc Pharmacol
  contributor:
    fullname: Kleinbongard
– volume: 5
  start-page: 865
  year: 2009
  end-page: 869
  ident: bib10
  article-title: Nitrate and nitrite in biology, nutrition and therapeutics
  publication-title: Nat Chem Biol
  contributor:
    fullname: Ahluwalia
– volume: 353
  start-page: 999
  year: 2005
  end-page: 1007
  ident: bib3
  article-title: Circulating endothelial progenitor cells and cardiovascular outcomes
  publication-title: N Engl J Med
  contributor:
    fullname: Schiegl
– start-page: 317
  year: 2005
  end-page: 325
  ident: bib1
  article-title: Polyphenols and disease risk in epidemiologic studies
  publication-title: Am J Clin Nutr
  contributor:
    fullname: Hollman
– volume: 119
  start-page: 1433
  year: 2009
  end-page: 1441
  ident: bib2
  article-title: Cocoa and cardiovascular health
  publication-title: Circulation
  contributor:
    fullname: Luscher
– volume: 51
  start-page: 2141
  year: 2008
  end-page: 2149
  ident: bib11
  article-title: Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Heiss
– volume: 103
  start-page: 1024
  year: 2006
  ident: 10.1016/j.jacc.2010.03.039_bib7
  article-title: (−)-epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0510168103
  contributor:
    fullname: Schroeter
– volume: 5
  start-page: 865
  year: 2009
  ident: 10.1016/j.jacc.2010.03.039_bib10
  article-title: Nitrate and nitrite in biology, nutrition and therapeutics
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.260
  contributor:
    fullname: Lundberg
– volume: 49
  start-page: 741
  year: 2007
  ident: 10.1016/j.jacc.2010.03.039_bib5
  article-title: Endothelial progenitor cells in cardiovascular disorders
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.09.050
  contributor:
    fullname: Shantsila
– volume: 119
  start-page: 1433
  year: 2009
  ident: 10.1016/j.jacc.2010.03.039_bib2
  article-title: Cocoa and cardiovascular health
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.827022
  contributor:
    fullname: Corti
– start-page: 317
  issue: 81 Suppl
  year: 2005
  ident: 10.1016/j.jacc.2010.03.039_bib1
  article-title: Polyphenols and disease risk in epidemiologic studies
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/81.1.317S
  contributor:
    fullname: Arts
– volume: 82
  start-page: 671
  year: 2004
  ident: 10.1016/j.jacc.2010.03.039_bib4
  article-title: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?
  publication-title: J Mol Med
  doi: 10.1007/s00109-004-0580-x
  contributor:
    fullname: Dimmeler
– volume: 45
  start-page: 1441
  year: 2005
  ident: 10.1016/j.jacc.2010.03.039_bib8
  article-title: Impaired progenitor cell activity in age-related endothelial dysfunction
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2004.12.074
  contributor:
    fullname: Heiss
– volume: 353
  start-page: 999
  year: 2005
  ident: 10.1016/j.jacc.2010.03.039_bib3
  article-title: Circulating endothelial progenitor cells and cardiovascular outcomes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa043814
  contributor:
    fullname: Werner
– volume: 47
  start-page: 2130
  year: 2006
  ident: 10.1016/j.jacc.2010.03.039_bib6
  article-title: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.04.026
  contributor:
    fullname: Smith
– volume: 49
  start-page: 74
  year: 2007
  ident: 10.1016/j.jacc.2010.03.039_bib9
  article-title: Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/FJC.0b013e31802d0001
  contributor:
    fullname: Heiss
– volume: 51
  start-page: 2141
  year: 2008
  ident: 10.1016/j.jacc.2010.03.039_bib11
  article-title: Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.01.059
  contributor:
    fullname: Balzer
SSID ssj0006819
Score 2.4690263
Snippet Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary...
In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention...
OBJECTIVESIn patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 218
SubjectTerms angiogenic cells
Bioavailability
Biological and medical sciences
Blood Pressure
Cacao
Cardiology
Cardiology. Vascular system
Cardiovascular
Cardiovascular disease
Cholesterol
coronary artery disease
Coronary Disease - diet therapy
Coronary Disease - physiopathology
Coronary heart disease
Diet
Diseases of the digestive system
Double-Blind Method
Drug therapy
Endothelial Cells - physiology
Endothelium, Vascular - drug effects
Endothelium, Vascular - physiology
Enzymes
Female
flavanols
Flavonoids - administration & dosage
Flavonoids - pharmacology
Flow velocity
flow-mediated vasodilation
Heart
Heart rate
Humans
Internal Medicine
Intervention
Lipoproteins
Male
Medical sciences
Middle Aged
Mortality
Neovascularization, Physiologic - physiology
nutrition
Plasma
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Statins
Studies
Variance analysis
Vascular endothelial growth factor
Vasodilation - physiology
Title Improvement of Endothelial Function With Dietary Flavanols Is Associated With Mobilization of Circulating Angiogenic Cells in Patients With Coronary Artery Disease
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0735109710017365
https://dx.doi.org/10.1016/j.jacc.2010.03.039
https://www.ncbi.nlm.nih.gov/pubmed/20620742
https://www.proquest.com/docview/1506270764
https://search.proquest.com/docview/733984529
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdpB2Mwxr7nrSt62FtwSazYlh9LmpAOMsba0bEX4Q-5czB2qZOH9t_pP7o7SZadhY5tMDAmUSxb4X6-O51-dyLkQ5CwKJV-4E5YCidwGVwe-JHr-bGfp6D-Qo65w4uz8NM3fjKbzAaDdt_Rru2_ShraQNaYOfsX0rY3hQb4DDKHM0gdzn8kdx0lkO0a_6zKMMeqxMD4HGyYEvcFBl9PCrlGyty8jMGbrstmeNpYaYEbqi5a1kievbV-5bS4TtWGXxhMqS6LGsZRpMOpLEtFrP2sy7Q2uvcUyyPgM46ROHqDpT7tatCuQ9xLcqn6AY2posz2o_8LWTS90gg9hH-Mf1Q7ge4uKrGUJabU21UmqbY7GF7IKrsZLg2fyMRAcPk-dHUKqw7Mtck5W9xRUF5YZFXTf4-k0e8-d5lv2owB0JXNDdDZljbnPcfA08neOzZHhz9WR6s4TQ1XkMERdRbW8h7PcEw4JKx8FbLA3yMPPNCQqKC_-1-sCxFwtSON_Qcm20sTE399zn0e1eOruIH3PNcbtNw_g1Ke1PlT8sRInB5r7D4jA1k9Jw-XhuTxgtz1IEzrnPYgTFsIU8QXNRCmFsL0tKEdhPVFfQjj7XoQph2EqYIwLSraQlj3biFMNYSpgfBL8nU-O58uXLOXiJuCS7t2Yy-I0J-VYKF4PE6SBObuSRTKUZxkWR6N8zhnIY-SLBhj-YOcxxPJVTyBT0Zhxl6R_aqu5BtCYY6QcOycRRmW9kzSlAU8zbF4JXzNHTJs5SGudMkY0XIpVwKlJ1B6YsTgiBwStiITbTI0mG_ZGJ3SiLFoPDESO9hxiG97GndZu8ECkPnbJx5uIcMO0mNYGmrMHHLQQkV0o_CxoPkoDCYOofZnsEW4wBhXst40ImQs4sjkcMhrjbDu3tAbw3Bv_3HQ78ij7sU_IPvr6418T_aabHOoXp2fOE0Pdg
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+of+Endothelial+Function+With+Dietary+Flavanols+Is+Associated+With+Mobilization+of+Circulating+Angiogenic+Cells+in+Patients+With+Coronary+Artery+Disease&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Heiss%2C+Christian&rft.au=Jahn%2C+Sarah&rft.au=Taylor%2C+Melanie&rft.au=Real%2C+Wendy+May&rft.date=2010-07-13&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.eissn=1558-3597&rft.volume=56&rft.issue=3&rft.spage=218&rft.epage=224&rft_id=info:doi/10.1016%2Fj.jacc.2010.03.039&rft.externalDocID=S0735109710017365
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109710X00250%2Fcov150h.gif